EGFR and glioblastoma: For example, glioblastoma samples with mutations in EGFR’s dimerization interface have higher levels of both EGFR and phosphorylated EGFR (Y992 and Y1173) proteins than patients with other EGFR mutations (Fig 4), suggesting that EGFR signaling is stronger in these patients.